GSK to buy 35Pharma, picking up lung disease drug

Andrew Joseph covers well being, medication, and the biopharma business in Europe. You’ll be able to attain Andrew on Sign at drewqjoseph.71.

LONDON — Build up its base of medicines for lung illnesses, GSK mentioned Wednesday it was shopping for the privately held agency 35Pharma for $950 million in money.

The centerpiece of the deal is an experimental drug referred to as HS235 that’s set to start out trials in pulmonary arterial hypertension, a type of hypertension within the lungs. 

The illness has more and more grow to be a goal for drugmakers in recent times. Merck’s Winrevair received approval for PAH in 2024, and reached $1.4 billion in gross sales final yr.